WHO ICTRP trial

A Randomized Trial to Evaluate the Effect of Adjunctive Antiplatelet Therapy…

EUCTR2007-003701-27-DE · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2007-003701-27-DE
Public title A Randomized Trial to Evaluate the Effect of Adjunctive Antiplatelet Therapy with Intravenous PRT060128, a Selective P2Y12-Receptor Inhibitor, Before Primary Percutaneous Intervention in Patients with ST-Elevation Myocardial Infarction - ERASE-MI
Scientific title A Randomized Trial to Evaluate the Effect of Adjunctive Antiplatelet Therapy with Intravenous PRT060128, a Selective P2Y12-Receptor Inhibitor, Before Primary Percutaneous Intervention in Patients with ST-Elevation Myocardial Infarction - ERASE-MI
Primary sponsor Portola Pharmaceuticals, Inc.
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Countries Germany;Austria
Conditions Adjunctive antiplatelet therapy prior to primary percutaneous intervention in patients with ST-Elevation Myocardial Infarction (STEMI) MedDRA version: 9.1 Level: LLT Classification code 10000891 Term: Acute myocardial infarction
Interventions Product Name: PRT060128 Potassium Product Code: PRT0606128 Pharmaceutical Form: Powder for solution for injection Current Sponsor code: PRT060128 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20…
Registration date Sep 10, 2007
Target size 220
Secondary IDs 07-113
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations